Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-013502
Filing Date
2015-10-01
Accepted
2015-10-01 16:08:24
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3165
  Complete submission text file 0001179110-15-013502.txt   4826
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Issuer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36855 | Film No.: 151137091